GPC spin column HPLC-ESI-MS methods for screening drugs noncovalently bound to proteins

Area of Science:

• Biochemistry
• Analytical Chemistry
• Pharmacology

Background:

• Accurate determination of drug-protein interactions is crucial for drug discovery.
• Non-covalent binding is a key factor in drug efficacy and specificity.
• Existing screening methods may lack sensitivity or resolution for complex interactions.

Purpose of the Study:

• To develop and validate a robust secondary drug screening method.
• To quantify the degree of non-covalent binding between drug candidates and therapeutic proteins.
• To illustrate the utility of the method using geldanamycin and Hsp90cat.

Main Methods:

• Gel centrifugation chromatography (GPC) spin columns for isolating native protein-drug complexes.
• Reversed-phase High-Performance Liquid Chromatography (HPLC) coupled with Electrospray Ionization Mass Spectrometry (ESI-MS) for sensitive detection.
• Combined native and denaturing conditions for comprehensive analysis.

Main Results:

• The GPC spin column HPLC-ESI-MS method effectively isolates and detects protein-drug complexes.
• The methodology provides highly resolved and sensitive detection of drugs within complexes.
• Demonstrated successful application in screening non-covalent binding of geldanamycin with Hsp90cat.

Conclusions:

• The described methodology offers a powerful tool for secondary drug screening.
• This approach enables precise quantification of non-covalent drug-protein binding.
• The technique has significant implications for advancing drug discovery and development.